Aetna covers weight loss medication on some plans and excludes it entirely on others. Coverage depends on the specific plan, employer decisions, and whether the drug holds FDA approval for obesity treatment. There’s no single answer that applies to every Aetna member.
Large employer-sponsored plans are the most common source of GLP-1 coverage, while individual and ACA plans typically exclude it. Prior authorization is almost always required. Aetna sets strict BMI thresholds and demands at least six months of documented lifestyle program participation before any medication claim is considered.
This guide covers Wegovy, Ozempic, and Zepbound coverage rules, prior authorization criteria, costs without Aetna coverage, and what to do if a claim is denied. The team at Eat Proteins breaks it all down so members can understand their options and take the right next step.
Does Aetna Cover Weight Loss Medication?
Aetna weight loss medication coverage varies significantly by plan, with some plans covering FDA-approved drugs like Wegovy and Zepbound while many others explicitly exclude them under the pharmacy or health benefit. There’s no single Aetna-wide policy. Coverage depends entirely on which plan a member holds.
Here’s the thing: Aetna administers hundreds of different plan designs. Each carries its own formulary, exclusion list, and prior authorization requirements. Two people with identical Aetna cards from different employers can have completely different outcomes.
And it gets more complicated. Many Aetna benefit plans specifically exclude weight reduction medications. When a plan document contains an anti-obesity medication exclusion, claims are denied regardless of medical necessity or BMI. So the first step is always checking the plan document itself.
What Types of Weight Loss Medications Does Aetna Cover?
Covered weight loss medications through Aetna may include Wegovy (semaglutide), Saxenda (liraglutide), Zepbound (tirzepatide), Qsymia (phentermine/topiramate), and orlistat, depending on the specific plan formulary. GLP-1 agonists like Wegovy and Zepbound are the most discussed, but coverage differs per plan.
Here’s what most people get wrong: Ozempic is not covered for weight loss through most Aetna plans. Ozempic is FDA-approved for type 2 diabetes only, not obesity. Plans following FDA-approved indications exclude it for weight management purposes, and that’s a hard rule.
Plenity, an FDA-cleared weight reduction device, qualifies as medically necessary under Aetna criteria for adults with a BMI of 25-40 kg/m2 (55-88 lbs above standard weight range) when used alongside diet and exercise.
Medications Aetna May Cover for Weight Loss:
- Wegovy (semaglutide) — FDA-approved for obesity management
- Saxenda (liraglutide) — FDA-approved for chronic weight management
- Zepbound (tirzepatide) — covered on select plans only
- Qsymia (phentermine/topiramate) — covered as preferred on some plans
- Orlistat (Xenical) — covered for BMI of 30 kg/m2 or greater
- Plenity — medically necessary device for BMI of 25-40 kg/m2
Which Aetna Plans Are Most Likely to Include Coverage?
Large employer-sponsored plans are the most common source of GLP-1 weight loss medication coverage, as employers choose whether to include anti-obesity drugs in their formulary. Some large employers have added Wegovy and Zepbound. Many haven’t.
In fact, self-funded plans administered by Aetna give employers full formulary authority. The employer’s benefits team, not Aetna, decides which weight loss medications are covered. Coverage varies completely from one employer to the next.
Individual plans, ACA marketplace plans, and short-term plans are the least likely to cover weight loss medications. Anti-obesity drugs aren’t required under ACA essential health benefits, so most individual market plans exclude them entirely.
Aetna Plan Coverage Likelihood:
| Plan Type | Coverage Likelihood | Who Decides |
| Large employer-sponsored | Moderate to high | Employer benefits team |
| Self-funded (Aetna administered) | Varies by employer | Employer benefits team |
| Medicare Advantage | Low but increasing | Plan design |
| ACA marketplace | Low | Plan design |
| Individual/short-term plans | Very low | Plan document exclusions |
How Does Aetna Decide Coverage for Weight Loss Drugs?
Aetna weight loss drug coverage decisions are driven by formulary design, plan documents, and employer benefit selections, not a single company-wide clinical policy. Aetna negotiates drug pricing through formulary tiers, but employers and plan sponsors set the final inclusion or exclusion of specific medications.
To be clear: Aetna requires weight reduction medications to serve as an adjunct to caloric restriction, exercise, and behavioral modification. Approval comes only when those non-medication measures haven’t produced adequate weight loss. That prerequisite matters more than most people realize.
What Is Prior Authorization for Weight Loss Medication?
Prior authorization is a mandatory review process where a prescribing clinician submits documentation to Aetna proving a medication is medically necessary before the plan will approve or cover it. Aetna reviews the submitted criteria and either grants or denies the authorization before the prescription is filled.
And here’s the kicker: prior authorization is almost always required even when a plan covers Wegovy or Zepbound. PA criteria are similar for both medications. Both must meet plan-specific medical necessity thresholds before any claim is processed.
So what does that mean in practice? Prior authorization documentation must confirm the patient participated in a comprehensive weight management program, including lifestyle changes, a reduced-calorie diet, and increased physical activity for a minimum of six months before the medication request is submitted.
What Criteria Must a Patient Meet for Approval?
Aetna requires a BMI of 30 kg/m2 or greater (equivalent to obesity), or a BMI of 27 kg/m2 (overweight range) with at least one weight-related comorbidity such as high cholesterol, type 2 diabetes, hypertension, or sleep apnea, to qualify for weight loss medication coverage.
The patient must be 18 years or older, must not be using two weight loss medications simultaneously, and must have no contraindications to the requested drug. The medication must be prescribed for an FDA-approved indication and used within that scope.
Documentation must confirm active enrollment in a weight loss program combining a reduced-calorie diet and increased physical activity. Clinician attestation of medical necessity must accompany the prior authorization submission. Missing any single item can delay or kill the approval.
Aetna Prior Authorization Checklist:
- BMI of 30 kg/m2 or greater, OR BMI of 27 kg/m2 with qualifying comorbidity
- Participation in a comprehensive weight management program for at least 6 months
- Patient is 18 years of age or older
- No concurrent use of two weight loss medications
- No contraindications to the requested drug
- Medication prescribed for FDA-approved indication
- Clinician attestation of medical necessity on file
Does Aetna Cover Wegovy for Weight Loss?
Wegovy (semaglutide) coverage through Aetna is available on some plans because Wegovy holds FDA approval specifically for obesity treatment, making it eligible for anti-obesity medication coverage where the formulary allows it. Coverage is plan-specific and not guaranteed across all Aetna products.
The good news? Aetna has announced continued coverage for Wegovy and Saxenda (liraglutide) across multiple plan types, even after dropping Zepbound from some formularies in mid-2025. Wegovy remains one of the more consistently covered GLP-1 options among Aetna plans right now.
What Are the Requirements to Get Wegovy Approved by Aetna?
Initial Wegovy approval through Aetna requires a BMI of 30 kg/m2 or greater, confirmed participation in a qualifying weight management program, no concurrent use of another weight loss drug, and clinician attestation of medical necessity. All criteria must be documented before prior authorization is submitted.
For continued Wegovy coverage at renewal, Aetna requires completion of at least three months of therapy and documented weight loss progress meeting the plan’s renewal benchmarks. Short answer: show the medication is working.
Members can verify Wegovy coverage by logging in to the Aetna member portal and searching for ‘semaglutide’ in the formulary lookup tool. A plan may cover Wegovy but not Zepbound, or vice versa, so both must be checked separately.
Steps to Get Wegovy Approved by Aetna:
- Check the Aetna member portal formulary for ‘semaglutide’ to confirm Wegovy is covered on your plan.
- Enroll in a qualifying weight management program and document participation for at least 6 months.
- Have your clinician gather BMI documentation and comorbidity records.
- Submit prior authorization paperwork through your clinician with all required documentation.
- Await Aetna review (typically 2-7 business days for a complete submission).
- If denied, initiate the formal appeals process with additional supporting documentation.
Does Aetna Cover Ozempic for Weight Loss?
Aetna does not typically cover Ozempic for weight loss. Coverage for Ozempic is generally limited to patients with confirmed type 2 diabetes who meet the plan’s formulary and prior authorization requirements for diabetes management. Weight-only prescriptions are excluded from coverage in most plans.
Here’s why that matters. Ozempic is FDA-approved for type 2 diabetes, not obesity. Most Aetna plans follow FDA-approved indications when determining drug eligibility. A weight-only Ozempic prescription falls outside those approved uses. It’s denied under standard plan rules, and appeals rarely succeed on that basis alone.
Ready to speed things up? Get a proven weight loss plan built around the same principles Aetna’s approved programs require.
When Will Aetna Cover Ozempic?
Aetna covers Ozempic when a patient has a confirmed type 2 diabetes diagnosis and meets the plan’s formulary criteria and prior authorization requirements tied to diabetes management, not weight loss. Coverage requires a diabetes-primary clinical indication.
Prior authorization for Ozempic through Aetna requires a healthcare provider to submit documentation showing medical necessity based on the diabetes diagnosis. A weight management rationale alone isn’t sufficient for approval under most Aetna plan terms.
Does Aetna Cover Zepbound for Weight Loss?
Zepbound (tirzepatide) coverage for weight loss is limited across Aetna plans. In mid-2025, Aetna announced some plans would remove Zepbound from their formularies while continuing coverage of Wegovy, Saxenda, Qsymia, and orlistat for weight management.
At the same time, coverage is not gone across the board. As of publication, Aetna Basic Control with ACSF still covers Zepbound for weight loss. Aetna Advanced Control, Aetna Standard Control, Aetna Advanced Control Choice, and Aetna Standard Control Choice with ACSF list Zepbound as excluded in their 2026 formularies.
Aetna Plans That Exclude Zepbound for Weight Loss (2026):
- Aetna Advanced Control Choice
- Aetna Advanced Control Plan
- Aetna Standard Control
- Aetna Standard Control Choice with ACSF
Does Aetna Cover Zepbound for Obstructive Sleep Apnea?
Some Aetna plans cover Zepbound for obstructive sleep apnea (OSA). Zepbound is the only FDA-approved medication for OSA, which gives it a distinct coverage pathway separate from weight management indications on plans that specifically address sleep apnea treatment.
Coverage for Zepbound for OSA varies by Aetna plan. Certain Aetna Better Health Medicaid plans include it for this indication. Members must review their specific plan documents or call the member services number on their card to confirm eligibility for OSA coverage.
What Are the Risks of Relying on Insurance for Weight Loss Drugs?
Relying on Aetna insurance for weight loss drug access carries real financial risk. Plans with explicit anti-obesity medication exclusions deny GLP-1 drug claims regardless of medical necessity, leaving members responsible for full retail costs that often exceed $1,000 per month.
And it gets worse. Mid-year plan changes add another layer of uncertainty. In mid-2025, Aetna removed Zepbound from some formularies. Members already on therapy faced coverage gaps. They had to either switch medications or absorb full out-of-pocket costs without warning.
What Happens If Aetna Denies Your Claim?
A denied Aetna weight loss medication claim can be appealed through Aetna’s formal appeals process, which requires clinician documentation supporting medical necessity and may include an external independent review if the internal appeal is also denied.
When appeals fail, members can explore manufacturer savings programs for brand-name GLP-1 medications, compounding pharmacy options for lower-cost semaglutide, or alternative weight management medications already covered under their current plan formulary.
Who Should Not Rely on Aetna for Weight Loss Medication Coverage?
Patients on individual plans, ACA marketplace plans, or any plan containing an explicit anti-obesity medication exclusion should not rely on Aetna for weight loss drug coverage and should identify alternative access pathways before starting medication therapy.
Bottom line: members with a BMI below 30 kg/m2 and no qualifying comorbidity such as diabetes, hypertension, or sleep apnea are unlikely to meet Aetna’s medical necessity criteria. Those patients face high denial rates regardless of plan type.
How Much Do Weight Loss Medications Cost Without Aetna Coverage?
Weight loss medications cost significantly more without Aetna coverage. Retail prices for Wegovy and Zepbound regularly exceed $1,000 per month (approximately 840 British pounds) at standard pharmacy pricing, making long-term treatment financially unsustainable for most patients without insurance or assistance programs.
The good news? Generic and compounded alternatives offer lower entry points. Compounded semaglutide has been available for approximately $199 per month (about 165 British pounds) through certain pharmacies, though availability and quality standards vary by provider.
Weight Loss Medication Cost Comparison:
| Medication | Monthly Cost (Without Insurance) | With Assistance Program |
| Wegovy (semaglutide) | Over $1,300 per month | Varies by manufacturer program |
| Zepbound (tirzepatide) | Over $1,000 per month | Varies by manufacturer program |
| Saxenda (liraglutide) | Over $1,300 per month | Varies by manufacturer program |
| Compounded semaglutide | Approximately $199 per month | Not applicable |
| Medicare GLP-1 Bridge (from July 2026) | $50 per month (eligible members) | CMS program |
Are There Free or Low-Cost Weight Loss Programs Through Aetna?
Aetna Personal Health Solutions offers zero-cost weight loss programs for qualifying members, including Weight Watchers, HabitNu (a CDC-developed diabetes prevention program), Digbi Health, Betr Health, Ciba Health, and Transform for eligible plan participants.
And here’s the best part: the CVS Weight Management program is available as an add-on for Aetna members on GLP-1 therapy. Our nutritionists at Eat Proteins recommend pairing this kind of structured support with medication. It provides one-on-one dietitian coaching, a personalized nutrition plan, behavioral strategies, connected tracking devices, and an AI-powered digital app.
How Long Does It Take to Get Approved for Weight Loss Medication?
Prior authorization approvals for weight loss medications through Aetna typically take 2-7 business days once a clinician submits complete documentation, though incomplete submissions significantly extend the review timeline and may require additional rounds of documentation.
Pay attention to this: the six-month weight management program prerequisite adds considerable lead time before PA submission is even eligible. Members must complete at least six months of documented diet, exercise, and behavioral modification before Aetna considers prior authorization for Wegovy or Zepbound. Plan accordingly.
What Results Can You Expect from Covered Weight Loss Medications?
Clinical trials show Wegovy (semaglutide) produces an average body weight reduction of approximately 15 percent. Over 68 weeks, trial participants lost an average of 33 pounds (15 kilograms) when combining weekly injections with a reduced-calorie diet and exercise protocol. That’s meaningful, sustained progress.
But here’s what no one tells you: weight loss from these medications is generally temporary. Aetna’s own policy documentation states that weight tends to return after stopping medication unless permanent lifestyle changes including diet and physical activity are adopted and maintained. The medication starts it. The habits keep it.
Want Your Free Weight Loss Medication Coverage Guide from Eat Proteins?
You’ve got the facts. Now you need the plan. Our coaches at Eat Proteins built a free, step-by-step guide to navigating insurance coverage for weight loss medications, covering how to check formularies, meet prior authorization criteria, and appeal denied claims. It’s the roadmap most people wish they had from the start.
And there’s more. Eat Proteins also provides a free personalized nutrition and weight loss plan built to align with GLP-1 protocols like Wegovy and Zepbound. It’s designed to satisfy the diet and activity requirements Aetna demands as part of its approval criteria, so you’re building your coverage case while building your results.
How Can Eat Proteins Help You Navigate Insurance for Weight Loss?
The team at Eat Proteins guides members through the prior authorization process, helping document BMI thresholds, program participation history, and clinician requirements needed to meet Aetna’s medical necessity criteria for weight loss medication approval.
Eat Proteins provides structured nutrition protocols designed to work alongside GLP-1 therapy. The protocols address the diet and physical activity criteria Aetna requires, giving members a documented compliance record that supports their prior authorization submission.